Farrukh T Awan
Farrukh T Awan
UT Southwestern Medical Center
No verified email
Cited by
Cited by
Acalabrutinib (ACP-196) in relapsed chronic lymphocytic leukemia
JC Byrd, B Harrington, S O’Brien, JA Jones, A Schuh, S Devereux, ...
New England Journal of Medicine 374 (4), 323-332, 2016
Etiology of ibrutinib therapy discontinuation and outcomes in patients with chronic lymphocytic leukemia
KJ Maddocks, AS Ruppert, G Lozanski, NA Heerema, W Zhao, L Abruzzo, ...
JAMA oncology 1 (1), 80-87, 2015
Efficacy and safety of midostaurin in advanced systemic mastocytosis
J Gotlib, HC Kluin-Nelemans, TI George, C Akin, K Sotlar, O Hermine, ...
New England Journal of Medicine 374 (26), 2530-2541, 2016
BTKC481S-mediated resistance to ibrutinib in chronic lymphocytic leukemia
JA Woyach, AS Ruppert, D Guinn, A Lehman, JS Blachly, A Lozanski, ...
Journal of Clinical Oncology 35 (13), 1437, 2017
Ibrutinib treatment improves T cell number and function in CLL patients
M Long, K Beckwith, P Do, BL Mundy, A Gordon, AM Lehman, ...
The Journal of clinical investigation 127 (8), 3052-3064, 2017
Efficacy and safety of idelalisib in combination with ofatumumab for previously treated chronic lymphocytic leukaemia: an open-label, randomised phase 3 trial
JA Jones, T Robak, JR Brown, FT Awan, X Badoux, S Coutre, ...
The Lancet Haematology 4 (3), e114-e126, 2017
Hypertension and incident cardiovascular events following ibrutinib initiation
T Dickerson, T Wiczer, A Waller, J Philippon, K Porter, D Haddad, A Guha, ...
Blood, the Journal of the American Society of Hematology 134 (22), 1919-1928, 2019
Acalabrutinib monotherapy in patients with chronic lymphocytic leukemia who are intolerant to ibrutinib
FT Awan, A Schuh, JR Brown, RR Furman, JM Pagel, P Hillmen, ...
Blood advances 3 (9), 1553-1562, 2019
Wnt'er in liver: expression of Wnt and frizzled genes in mouse
G Zeng, F Awan, W Otruba, P Muller, U Apte, X Tan, C Gandhi, ...
Hepatology 45 (1), 195-204, 2007
Acalabrutinib monotherapy in patients with relapsed/refractory chronic lymphocytic leukemia: updated phase 2 results
JC Byrd, WG Wierda, A Schuh, S Devereux, JM Chaves, JR Brown, ...
Blood, The Journal of the American Society of Hematology 135 (15), 1204-1213, 2020
Higher doses of lenalidomide are associated with unacceptable toxicity including life-threatening tumor flare in patients with chronic lymphocytic leukemia
LA Andritsos, AJ Johnson, G Lozanski, W Blum, C Kefauver, F Awan, ...
Journal of clinical oncology: official journal of the American Society of …, 2008
Use of chimeric antigen receptor T cell therapy in clinical practice for relapsed/refractory aggressive B cell non-Hodgkin lymphoma: an expert panel opinion from the American …
T Jain, M Bar, AJ Kansagra, EA Chong, SK Hashmi, SS Neelapu, M Byrne, ...
Biology of Blood and Marrow Transplantation 25 (12), 2305-2321, 2019
Cumulative incidence, risk factors, and management of atrial fibrillation in patients receiving ibrutinib
TE Wiczer, LB Levine, J Brumbaugh, J Coggins, Q Zhao, AS Ruppert, ...
Blood advances 1 (20), 1739-1748, 2017
CD19 targeting of chronic lymphocytic leukemia with a novel Fc-domain–engineered monoclonal antibody
FT Awan, R Lapalombella, R Trotta, JP Butchar, B Yu, DM Benson Jr, ...
Blood, The Journal of the American Society of Hematology 115 (6), 1204-1213, 2010
The BTK inhibitor ARQ 531 targets ibrutinib-resistant CLL and Richter transformation
SD Reiff, R Mantel, LL Smith, JT Greene, EM Muhowski, CA Fabian, ...
Cancer discovery 8 (10), 1300-1315, 2018
Therapeutic CD94/NKG2A blockade improves natural killer cell dysfunction in chronic lymphocytic leukemia
EM McWilliams, JM Mele, C Cheney, EA Timmerman, F Fiazuddin, ...
Oncoimmunology 5 (10), e1226720, 2016
Genome-wide DNA methylation analysis reveals novel epigenetic changes in chronic lymphocytic leukemia
L Pei, JH Choi, J Liu, EJ Lee, B McCarthy, JM Wilson, E Speir, F Awan, ...
Epigenetics 7 (6), 567-578, 2012
Clinical practice recommendations for use of allogeneic hematopoietic cell transplantation in chronic lymphocytic leukemia on behalf of the Guidelines Committee of the American …
MA Kharfan-Dabaja, A Kumar, M Hamadani, S Stilgenbauer, P Ghia, ...
Biology of Blood and Marrow Transplantation 22 (12), 2117-2125, 2016
Phase 1b study of obinutuzumab, ibrutinib, and venetoclax in relapsed and refractory chronic lymphocytic leukemia
KA Rogers, Y Huang, AS Ruppert, FT Awan, NA Heerema, C Hoffman, ...
Blood, The Journal of the American Society of Hematology 132 (15), 1568-1572, 2018
How we approach patient evaluation for hematopoietic stem cell transplantation
M Hamadani, M Craig, FT Awan, SM Devine
Bone marrow transplantation 45 (8), 1259-1268, 2010
The system can't perform the operation now. Try again later.
Articles 1–20